Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3639

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-3639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural-formula.jpg (Structural Formula)

Structural-formula.jpg (Structural Formula)
Chemical structure of rosuvastatin calcium, showing two rosuvastatin molecules complexed with one calcium ion (Ca2+). The structure includes a fluorophenyl group, pyrimidine ring, sulfonamide moiety, and carboxylate groups.*
FDA Label Image

Figure-1-time-jupiter.jpg (Figure 1 Time Jupiter)

Figure-1-time-jupiter.jpg (Figure 1 Time Jupiter)
A cumulative incidence line graph comparing Rosuvastatin calcium (Rosuva) and placebo groups over 6 years. The x-axis shows years, and the y-axis shows cumulative incidence percentage. Rosuvastatin shows lower cumulative incidence than placebo, with hazard ratio (HR) 0.56 (95% CI 0.46-0.69) and P<0.001. Number at risk is shown below the graph for both groups at multiple time points.*
FDA Label Image

Figure-2-major-jupiter.jpg (Figure 2 Major Jupiter)

Figure-2-major-jupiter.jpg (Figure 2 Major Jupiter)
Data table showing clinical event rates comparing Rosuvastatin calcium 20 mg with placebo 20 mg in 8,901 patients each. It lists events such as primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization, with event numbers, rates, hazard ratios (HR) with 95% confidence intervals, and p-values. A hazard ratio plot illustrates the risk reduction for each endpoint with Rosuvastatin relative to placebo.*
FDA Label Image

Figure-3-percent-dyslipidemia.jpg (Figure 3 Percent Dyslipidemia)

Figure-3-percent-dyslipidemia.jpg (Figure 3 Percent Dyslipidemia)
A box plot chart comparing the percent change from baseline in LDL-C levels across different doses (10, 20, 40 mg) of four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The y-axis shows percent change from -75 to 0. Each statin's effect at varying doses is displayed with box plots indicating distribution and variability in LDL-C reduction.*
FDA Label Image

Mm1 (Rosuvastatin 10mg 70518 3639 00)

Mm1 (Rosuvastatin 10mg 70518 3639 00)
Rosuvastatin calcium 10 mg film-coated tablets packaging label showing a quantity of 30 tablets. The label includes the NDC number 70518-3639-00, distributor RemedyRepack Inc., and storage instructions to protect from moisture and keep between 20-25°C with permitted excursions to 15-30°C. The manufacturer is Biocon Pharma, Iselin, NJ.*
FDA Label Image

Mm2 (Rosuvastatin 10mg 70518 3639 01)

Mm2 (Rosuvastatin 10mg 70518 3639 01)
Rosuvastatin calcium 10 mg film-coated tablets packaging label indicating quantity of 50 tablets per box. The label shows the product is repackaged by RemedyRepack Inc., with storage instructions to protect from moisture and keep out of reach of children. Manufacturer information from Biocon Pharma, Iselin, NJ, is also included along with usual dosage instructions referencing the insert.*
FDA Label Image

Mm3 (Rosuvastatin 10mg 70518 3639 02)

Mm3 (Rosuvastatin 10mg 70518 3639 02)
Rosuvastatin calcium 10 mg tablet film coated packaging label with quantity of 1 tablet. Label includes NDC 70518-3639-02, instructions to protect from moisture, repackaged by RemedyRepack Inc. Indiana, PA, and storage temperature guidance. Manufacturer listed is Biocon Pharma, Iselin, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.